IMPACT OF TACRINE IN THE CARE OF PATIENTS WITH ALZHEIMERS-DISEASE - WHAT WE KNOW ONE-YEAR AFTER FDA APPROVAL

BLANK K CHEONG JA COHEN GD GAITZ C GOTTLIEB G KATZ IR LEUCHTER A MALETTA G MARGOLIN R SAKAUYE K SHAMOIAN C

K. Blank et al., IMPACT OF TACRINE IN THE CARE OF PATIENTS WITH ALZHEIMERS-DISEASE - WHAT WE KNOW ONE-YEAR AFTER FDA APPROVAL, The American journal of geriatric psychiatry, 2(4), 1994, pp. 285-289

7

Geiatric & Gerontology",Psychiatry

The American journal of geriatric psychiatry → ACNP

10647481

2

4

1994

285 - 289

ISI

1064-7481(1994)2:4<285:IOTITC>2.0.ZU;2-R